Fiji vs Philippines: Access to anti-retroviral drugs, female
Fiji
18.0%
in 2024
Philippines
21.0%
in 2024
Fiji rank
141st
Philippines rank
138th
Access to anti-retroviral drugs, female over time
- Fiji
- Philippines
How they compare
Philippines currently reports 21.0% against 18.0% in Fiji, a difference of 3.0%.
That makes Philippines's figure about 1.2 times Fiji's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Philippines ahead.
Fiji ranks 141st and Philippines ranks 138th of 141 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Philippines in 1.
Head to head by decade
| Decade | Fiji | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.8% | 3.5% | 47.3% | Fiji |
| 2010s | 45.9% | 13.2% | 32.7% | Fiji |
| 2020s | 17.8% | 21.0% | 3.2% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Fiji or Philippines?
- Philippines, at 21.0% against 18.0% in Fiji as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Fiji and Philippines?
- 3.0%, with Philippines ahead.
- How many years of comparable data are there for Fiji and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Philippines rank globally for access to anti-retroviral drugs, female?
- Fiji ranks 141st and Philippines ranks 138th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.